Skip to main content
OpenTrials

Clinical trial condition

Esophageal Squamous Cell Carcinoma

Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

208 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Squamous Cell Carcinoma trial results

Recruiting

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

NCT06780111

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • UPMC Hillman Cancer Center ( Site 1904) Pittsburgh, Pennsylvania, United States
  • Liga Norte Riograndense Contra o Cancer ( Site 1301) Natal, Rio Grande do Norte, Brazil
  • Hospital Nossa Senhora da Conceicao ( Site 1300) Porto Alegre, Rio Grande do Sul, Brazil
  • Clínica Puerto Montt ( Site 1406) Port Montt, Los Lagos Region, Chile
View all 41 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT07217171

Conditions
Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more
Locations
  • City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • The Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

NCT06644781

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Baptist Cancer Center Memphis, Tennessee, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 132 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

NCT07554521

Conditions
Advanced Gastroesophageal Adenocarcinoma, Advanced Unresectable Gastric Adenocarcinoma, Carcinoma, +14 more
Locations
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Bioresearch Partners Holding Hialeah Hospital Hialeah, Florida, United States
  • Florida Clinical Trials Group Plantation Plantation, Florida, United States
  • Florida Clinical Trials Group Tamarac Tamarac, Florida, United States
View Trial Details
Recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT05208762

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 62 locations
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details

Related conditions